Skip to content
OpenCapital
Get started

Research Solutions RSSS Business Segments — Allocated Share Based Compensation Expense

Similar metrics at other companies

Ocular Therapeutix logo
OCULSingle Reportable — Allocated Share Based Compensation Expense
$15.58M+49.0%
Edgewise Therapeutics, Inc. logo
EWTXSingle Reportable — Allocated Share Based Compensation Expense
$8.72M-3.8%
Vuzix logo
VUZISingle Reportable — Allocated Share Based Compensation Expense
$4.11M-24.0%
Payoneer Global Inc. logo
PAYOSingle Reportable — Allocated Share Based Compensation Expense
$18.52M-1.2%
Rigetti Computing, Inc. logo
RGTISingle Reportable — Allocated Share Based Compensation Expense
$5.89M+41.1%
Protagonist Therapeutics logo
PTGXSingle Reportable — Allocated Share Based Compensation Expense
$14.52M+5.2%

Other financials

Income statement

See full
Revenue$12.1M-4.3%
Gross profit$6.3M0.0%
Operating income$1.0M+87.6%
Net income$860.2K+297%
EPS (diluted)$0.03+200%

Balance sheet

See full
Cash & equivalents$12.1M+22.3%
Total equity$19.1M+69.7%
Total assets$45.9M+1.6%

Cash flow

See full
Operating cash flow$1.0M-65.2%
CapEx$4.0K-34.4%
Free cash flow$1.0M-65.2%

Valuation

See full
Market cap$77.6M-15.8%
P/E17.2×-55.7×
P/S1.6×-0.3×

Profitability

See full
Gross margin51.4%+3.2pp
Operating margin8.1%—
Net margin9.3%+6.3pp
FCF margin11.8%—

Returns & leverage

See full
Return on equity29.8%+19.8pp
Debt / equity0×—
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Research Solutions in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: Research Solutions’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Research Solutions's business segments — allocated share based compensation expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Research Solutions's business segments — allocated share based compensation expense?
Research Solutions (RSSS) reported business segments — allocated share based compensation expense of $248.61K in Q1 2026.
How has Research Solutions's business segments — allocated share based compensation expense changed year-over-year?
Research Solutions's business segments — allocated share based compensation expense decreased by 58.2% year-over-year, from $594.64K to $248.61K.
What does business segments — allocated share based compensation expense mean?
This represents the non-cash expense associated with equity-based awards granted to employees and management within the business segment. It is a critical component of total compensation that aligns the interests of the workforce with those of shareholders. Investors track this to understand the true cost of talent and the potential for shareholder dilution.